Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma.
Tumori
; 107(6): 542-549, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-33153416
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Bone and Bones
/
Carcinoma, Renal Cell
/
Biomarkers
/
Kidney Neoplasms
/
Anilides
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Tumori
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: